BioMarin shareholders approve 8M share increase in equity plan, re-elect all directors

BIOMARIN PHARMACEUTICAL INC

Shareholders approved 8M additional shares under the 2017 Equity Incentive Plan (157.3M for, 7.7M against).
All ten director nominees, including Elizabeth Anderson and Alexander Hardy, re-elected.
KPMG ratified as independent auditor for FY2025 with 168.6M votes in favor.
Advisory vote on executive compensation passed with over 93% support of votes cast.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.